Stephenson Jason R, Wang Xiaohan, Perfitt Tyler L, Parrish Walker P, Shonesy Brian C, Marks Christian R, Mortlock Douglas P, Nakagawa Terunaga, Sutcliffe James S, Colbran Roger J
Department of Molecular Physiology and Biophysics.
Vanderbilt Brain Institute.
J Neurosci. 2017 Feb 22;37(8):2216-2233. doi: 10.1523/JNEUROSCI.2068-16.2017. Epub 2017 Jan 27.
Characterizing the functional impact of novel mutations linked to autism spectrum disorder (ASD) provides a deeper mechanistic understanding of the underlying pathophysiological mechanisms. Here we show that a Glu183 to Val (E183V) mutation in the CaMKIIα catalytic domain, identified in a proband diagnosed with ASD, decreases both CaMKIIα substrate phosphorylation and regulatory autophosphorylation, and that the mutated kinase acts in a dominant-negative manner to reduce CaMKIIα-WT autophosphorylation. The E183V mutation also reduces CaMKIIα binding to established ASD-linked proteins, such as Shank3 and subunits of l-type calcium channels and NMDA receptors, and increases CaMKIIα turnover in intact cells. In cultured neurons, the E183V mutation reduces CaMKIIα targeting to dendritic spines. Moreover, neuronal expression of CaMKIIα-E183V increases dendritic arborization and decreases both dendritic spine density and excitatory synaptic transmission. Mice with a knock-in CaMKIIα-E183V mutation have lower total forebrain CaMKIIα levels, with reduced targeting to synaptic subcellular fractions. The CaMKIIα-E183V mice also display aberrant behavioral phenotypes, including hyperactivity, social interaction deficits, and increased repetitive behaviors. Together, these data suggest that CaMKIIα plays a previously unappreciated role in ASD-related synaptic and behavioral phenotypes. Many autism spectrum disorder (ASD)-linked mutations disrupt the function of synaptic proteins, but no single gene accounts for >1% of total ASD cases. The molecular networks and mechanisms that couple the primary deficits caused by these individual mutations to core behavioral symptoms of ASD remain poorly understood. Here, we provide the first characterization of a mutation in the gene encoding CaMKIIα linked to a specific neuropsychiatric disorder. Our findings demonstrate that this ASD-linked mutation disrupts multiple CaMKII functions, induces synaptic deficits, and causes ASD-related behavioral alterations, providing novel insights into the synaptic mechanisms contributing to ASD.
确定与自闭症谱系障碍(ASD)相关的新突变的功能影响,有助于更深入地从机制上理解潜在的病理生理机制。在此,我们表明,在一名被诊断为ASD的先证者中发现的CaMKIIα催化结构域中的谷氨酸183突变为缬氨酸(E183V)突变,会降低CaMKIIα底物磷酸化和调节性自身磷酸化,并且该突变激酶以显性负性方式发挥作用,降低CaMKIIα-WT自身磷酸化。E183V突变还会减少CaMKIIα与已确定的与ASD相关的蛋白质(如Shank3以及L型钙通道和NMDA受体的亚基)的结合,并增加完整细胞中CaMKIIα的周转。在培养的神经元中,E183V突变会减少CaMKIIα定位于树突棘。此外,CaMKIIα-E183V的神经元表达会增加树突分支,并降低树突棘密度和兴奋性突触传递。携带CaMKIIα-E183V敲入突变的小鼠前脑CaMKIIα总水平较低,定位于突触亚细胞组分的能力降低。CaMKIIα-E183V小鼠还表现出异常的行为表型,包括多动、社交互动缺陷和重复行为增加。总之,这些数据表明CaMKIIα在与ASD相关的突触和行为表型中发挥了之前未被认识到的作用。许多与自闭症谱系障碍(ASD)相关的突变会破坏突触蛋白的功能,但没有一个单一基因在所有ASD病例中占比超过1%。将这些个体突变导致的主要缺陷与ASD的核心行为症状联系起来的分子网络和机制仍知之甚少。在此,我们首次对与一种特定神经精神疾病相关的编码CaMKIIα的基因突变进行了表征。我们的研究结果表明,这种与ASD相关的突变会破坏多种CaMKII功能,诱导突触缺陷,并导致与ASD相关的行为改变,为导致ASD的突触机制提供了新的见解。